Phase II Study of Irinotecan plus S-1 Combination for Previously Untreated Advanced Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0601

Publisher： Karger

E-ISSN： 1423-0232|81|2|84-90

ISSN： 0030-2414

Source： Oncology, Vol.81, Iss.2, 2011-10, pp. : 84-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Trial of Weekly Paclitaxel in Previously Untreated Advanced Non-Small-Cell Lung Cancer

By  

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 224-228

Karger

Access to resources Recommend Favorite

Phase II Study of Irinotecan and Ifosfamide in Patients with Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 306-311

Karger

Access to resources Recommend Favorite

A Multicenter Phase II Study of the Combination of Irinotecan and Gemcitabine in Previously Treated Patients with Small-Cell Lung Cancer

By  

Oncology, Vol. 66, Iss. 3, 2004-06 ,pp. : 192-196

Karger

Access to resources Recommend Favorite

Phase II Study of a 3-Week Schedule of Irinotecan Combined with Cisplatin in Previously Untreated Extensive-Stage Small-Cell Lung Cancer

By  

Oncology, Vol. 73, Iss. 1-2, 2008-03 ,pp. : 76-80

Karger

Access to resources Recommend Favorite

Phase I Study of Cisplatin, Ifosfamide and Irinotecan with rhG-CSF Support in Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 56, Iss. 4, 1999-05 ,pp. : 301-307

Karger

Access to resources Recommend Favorite